|
|
|
Volumn 92, Issue 5, 2002, Pages 356-357
|
|
Comparative safety and efficacy of bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients [10]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOPLASMA FDP;
BLOOD CLOTTING FACTOR;
FRESH FROZEN PLASMA;
PLASMA SUBSTITUTE;
TRIBUTYL PHOSPHATE;
ADULT;
BLEEDING;
BLOOD DONOR;
BLOOD GROUP ABO SYSTEM;
BLOOD TRANSFUSION;
CARDIOPULMONARY BYPASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FREEZE DRYING;
HEMOSTASIS;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
INTERMETHOD COMPARISON;
LETTER;
MAJOR CLINICAL STUDY;
MEDICAL AUDIT;
PATIENT CARE;
POWDER;
PREOPERATIVE EVALUATION;
RISK ASSESSMENT;
RISK MANAGEMENT;
SCREENING TEST;
SIDE EFFECT;
VIRUS INACTIVATION;
ADULT;
BLOOD COAGULATION FACTORS;
BLOOD DONORS;
BLOOD TRANSFUSION;
CARDIOPULMONARY BYPASS;
DETERGENTS;
HEMOSTASIS;
HUMANS;
PLASMA;
SAFETY;
SINGLE-BLIND METHOD;
SOLVENTS;
|
|
EID: 0036073239
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (14)
|
|
References (10)
|
